Global Manufacturing and Quality Standards
The global supply chain for generics is highly concentrated, with India serving as the "Pharmacy of the World" in 2026. India possesses the largest number of FDA-approved manufacturing facilities outside the United States.
To ensure safety, all generic manufacturers must adhere to Current Good Manufacturing Practices (cGMP). This includes:
Batch-to-Batch Consistency: Ensuring every pill has the exact same strength and purity.
Stability Testing: Proving the drug does not break down over time in its final packaging.
Facility Inspections: Regular, unannounced "boots-on-the-ground" inspections by global health authorities to verify that the air filtration, water purity, and chemical handling meet international safety standards.
1 View